References
- Ierardi AM, Savasi V, Angileri SA, et al. Percutaneous high frequency microwave ablation of uterine fibroids: systematic review. Biomed Res Int. 2018;2018:2360107.
- Stewart EA. Uterine fibroids. Lancet. 2001;357(9252):293–298.
- Vitale SG, Padula F, Gulino FA. Management of uterine fibroids in pregnancy: recent trends. Curr Opin Obstet Gynecol. 2015;27(6):432–437.
- Levast F, Legendre G, Bouet PE, et al. Management of uterine myomas during pregnancy. Gynecol Obstet Fertil. 2016;44(6):350–354.
- Laganà AS, Vergara D, Favilli A, et al. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017;296(5):855–867.
- Yang Q, Mas A, Diamond MP, et al. The mechanism and function of epigenetics in uterine leiomyoma development. Reprod Sci. 2016;23(2):163–175.
- Vitale SG, Sapia F, Rapisarda AMC, et al. Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int. 2017; 2017:6848250.
- Pakrashi T. New hysteroscopic techniques for submucosal uterine fibroids. Curr Opin Obstet Gynecol. 2014;26(4):308–313.
- Rabinovici J, Inbar Y, Revel A, et al. Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Ultrasoun Obstet Gyn. 2007;30(5):771–777.
- van Overhagen H, Reekers JA. Uterine artery embolization for symptomatic leiomyomata. Cardiovasc Inter Rad. 2015;38(3):536–542.
- Yang Y, Hao Y, Zhang J, et al. Ultrasound-guided percutaneous microwave ablation for subserosal uterine myomas. J Minim Invas Gyn. 2019;26(3):544–550.
- Yang Y, Zhang J, Han Z, et al. Ultrasound-guided percutaneous microwave ablation for submucosal uterine fibroids. J Minim Invasive Gynecol. 2014;21(3):436–441.
- Zhao W-P, Han Z-Y, Zhang J, et al. A retrospective comparison of microwave ablation and high intensity focused ultrasound for treating symptomatic uterine fibroids. Eur J Radiol. 2015;84(3):413–417.
- Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99(2):290–300.
- National Institute of Cancer. Common Terminology Criteria for Adverse Events (CTCAE) v5.0.2017. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf
- Filippiadis DK, Binkert C, Pellerin O, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Inter Rad. 2017;40(8):1141–1146.
- Katsumori T, Asai S, Yokota H, et al. Volume of embolic agents in uterine artery embolization for leiomyoma: relation to baseline MRI. Minim Invasive Ther Allied Technol. 2019;28(3):186–193.
- Ghezzi F, Cromi A, Bergamini V, et al. Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas. Surg Endosc. 2007;21(11):2081–2085.
- Yang Y, Zhang J, Han Z, et al. Ultrasound-guided percutaneous microwave ablation for adenomyosis: efficacy of treatment and effect on ovarian function. Sci Rep. 2015;5:10034.
- Liu H, Zhang J, Han Z-Y, et al. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China. Int J Hyperthermia. 2016;32(8):876–880.